Pfizer Ventures (PV) (Pfizer Venture Investments, PVI)

https://www.pfizerventures.com

Pfizer Ventures (PV), the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. PV seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. *

	Start	2004-01-01 established
	Group	Pfizer (Group)
	Industry	venture capital
	Industry 2	pharmaceutical

	Region	United States (USA)
	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford.

		Record changed: 2025-03-05

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Pfizer (Group)

[1] Waters Corporation. (1/15/19). "Press Release: Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System". Milford, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com